Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 17 May 2018

Unal Guillemette, Alessandri-Gradt Elodie, Leoz Marie, Pavie Juliette, Lefèvre Clément, Panjo Henri, Charpentier Charlotte, Descamps Diane, Barin Francis, Simon François, Meyer Laurence, Plantier Jean-Christophe

Abstract excerpt

Background: To obtain reliable clinical data of human immunodeficiency virus type 1 group O (HIV-1/O) infection, and immunovirological responses to combination antiretroviral therapy (cART), in a large series of 101 patients. Methods: Piecewise linear models were used to estimate CD4 count before and after cART initiation. Kaplan-Meier survival curves were used to estimate time to reach clinical stage C before...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to France

Share to Genetic Variation

Share to HIV Infections

Share to Viral Load

Source

Identifiers

PMID: 29272369
DOI: 10.1093/cid/cix1087

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals.PMID 29272369Read ↗

[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data].Semantic proximity Read ↗

HIV-1 Group O Origin, Evolution, Pathogenesis, and Treatment: Unraveling the Complexity of an Outlier 25 Years Later.Semantic proximity Read ↗

Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays.Semantic proximity Read ↗

Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.Semantic proximity Read ↗

HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges.Semantic proximity Read ↗

Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.Semantic proximity Read ↗

Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analysesSemantic proximity Read ↗

Triple HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient.Semantic proximity Read ↗

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.Semantic proximity Read ↗

A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection.Semantic proximity Read ↗

Evaluating individuals with extreme phenotypes of HIV-1 contributes towards better healthcare management of all HIV-1 positive individualsSemantic proximity Read ↗

Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.